Skip to main content
Top
Published in: Acta Diabetologica 6/2020

Open Access 01-06-2020 | Microalbuminuria | Original Article

Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study

Authors: Sunny S. Singh, Jeanine E. Roeters-van Lennep, Roosmarijn F. H. Lemmers, Thijs T. W. van Herpt, Aloysius G. Lieverse, Eric J. G. Sijbrands, Mandy van Hoek

Published in: Acta Diabetologica | Issue 6/2020

Login to get access

Abstract

Aims

Type 2 diabetes mellitus is a major cause of death and disability due to its long-term macro- and microvascular diseases. Although women with type 2 diabetes have more macrovascular diseases, it is unclear whether there are sex differences in the occurrence of microvascular disease. The aim of our study was to investigate sex differences in the incidence of microvascular complications in type 2 diabetes.

Methods

Analyses were performed in the DiaGene study, a prospective cohort study for complications of type 2 diabetes, collected in the city of Eindhoven, the Netherlands (n = 1886, mean follow-up time = 6.93 years). Cox proportional hazard models adjusted for risk factors for complications (age, smoking, hypertension, dyslipidemia, HbA1c and duration of type 2 diabetes) were used to analyze the incidence of microvascular complications in men and women.

Results

The incidence of microalbuminuria was significantly higher in men (HR microalbuminuria 1.64 [CI 1.21–2.24], p = 0.002). Additionally, men are more likely to develop two or three microvascular complications compared to women (OR 2.42 [CI 1.69–3.45], p < 0.001).

Conclusions

This study shows that men with type 2 diabetes are more likely to develop microvascular complications, especially microalbuminuria. Furthermore, men seem to have a higher chance of developing multiple microvascular complications. Our results highlight that men and women may not benefit to a similar extent from current treatment approaches to prevent diabetes-related microvascular diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gatling W, Budd S, Walters D, Mullee MA, Goddard JR, Hill RD (1998) Evidence of an increasing prevalence of diagnosed diabetes mellitus in the Poole area from 1983 to 1996. Diabet Med 15(12):1015–1021PubMed Gatling W, Budd S, Walters D, Mullee MA, Goddard JR, Hill RD (1998) Evidence of an increasing prevalence of diagnosed diabetes mellitus in the Poole area from 1983 to 1996. Diabet Med 15(12):1015–1021PubMed
2.
3.
go back to reference Arnetz L, Ekberg NR, Alvarsson M (2014) Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes 7:409–420PubMedPubMedCentral Arnetz L, Ekberg NR, Alvarsson M (2014) Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes 7:409–420PubMedPubMedCentral
4.
go back to reference Szalat A, Raz I (2008) Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women. Diabetes Obes Metab 10(12):1135–1156PubMed Szalat A, Raz I (2008) Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women. Diabetes Obes Metab 10(12):1135–1156PubMed
5.
go back to reference Stratton IM, Kohner EM, Aldington SJ et al (2001) UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44(2):156–163PubMed Stratton IM, Kohner EM, Aldington SJ et al (2001) UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44(2):156–163PubMed
6.
go back to reference Yang JY, Kim NK, Lee YJ et al (2013) Prevalence and factors associated with diabetic retinopathy in a Korean adult population: the 2008–2009 Korea National Health and Nutrition Examination Survey. Diabetes Res Clin Pract 102(3):218–224PubMed Yang JY, Kim NK, Lee YJ et al (2013) Prevalence and factors associated with diabetic retinopathy in a Korean adult population: the 2008–2009 Korea National Health and Nutrition Examination Survey. Diabetes Res Clin Pract 102(3):218–224PubMed
7.
go back to reference Pop-Busui R, Lu J, Lopes N, Jones TL, Investigators BD (2009) Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst 14(1):1–13PubMedPubMedCentral Pop-Busui R, Lu J, Lopes N, Jones TL, Investigators BD (2009) Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst 14(1):1–13PubMedPubMedCentral
8.
go back to reference Liu Z, Fu C, Wang W, Xu B (2010) Prevalence of chronic complications of type 2 diabetes mellitus in outpatients—a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes 8:62PubMedPubMedCentral Liu Z, Fu C, Wang W, Xu B (2010) Prevalence of chronic complications of type 2 diabetes mellitus in outpatients—a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes 8:62PubMedPubMedCentral
9.
go back to reference Gall MA, Hougaard P, Borch-Johnsen K, Parving HH (1997) Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 314(7083):783–788PubMedPubMedCentral Gall MA, Hougaard P, Borch-Johnsen K, Parving HH (1997) Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 314(7083):783–788PubMedPubMedCentral
10.
go back to reference Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R (1998) Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158(9):998–1004PubMed Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R (1998) Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158(9):998–1004PubMed
11.
go back to reference Crook ED, Patel SR (2004) Diabetic nephropathy in African-American patients. Curr Diab Rep 4(6):455–461PubMed Crook ED, Patel SR (2004) Diabetic nephropathy in African-American patients. Curr Diab Rep 4(6):455–461PubMed
12.
go back to reference van Herpt TTW, Lemmers RFH, van Hoek M et al (2017) Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes. Diabetol Metab Syndr 9:47PubMedPubMedCentral van Herpt TTW, Lemmers RFH, van Hoek M et al (2017) Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes. Diabetol Metab Syndr 9:47PubMedPubMedCentral
13.
go back to reference A American Diabetes (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1):S81–90 A American Diabetes (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1):S81–90
14.
go back to reference Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553PubMed Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539–553PubMed
15.
go back to reference Ossewaarde ME, Bots ML, Verbeek AL et al (2005) Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 16(4):556–562PubMed Ossewaarde ME, Bots ML, Verbeek AL et al (2005) Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 16(4):556–562PubMed
16.
go back to reference Looker HC, Nyangoma SO, Cromie D et al (2012) Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 55(9):2335–2342PubMedPubMedCentral Looker HC, Nyangoma SO, Cromie D et al (2012) Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 55(9):2335–2342PubMedPubMedCentral
17.
go back to reference Semeraro F, Parrinello G, Cancarini A et al (2011) Predicting the risk of diabetic retinopathy in type 2 diabetic patients. J Diabetes Complicat 25(5):292–297PubMed Semeraro F, Parrinello G, Cancarini A et al (2011) Predicting the risk of diabetic retinopathy in type 2 diabetic patients. J Diabetes Complicat 25(5):292–297PubMed
18.
go back to reference Ozawa GY, Bearse MA Jr, Adams AJ (2015) Male–female differences in diabetic retinopathy? Curr Eye Res 40(2):234–246PubMed Ozawa GY, Bearse MA Jr, Adams AJ (2015) Male–female differences in diabetic retinopathy? Curr Eye Res 40(2):234–246PubMed
19.
go back to reference Al-Rubeaan K, Youssef AM, Subhani SN et al (2014) Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. PLoS One 9(2):e88956PubMedPubMedCentral Al-Rubeaan K, Youssef AM, Subhani SN et al (2014) Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. PLoS One 9(2):e88956PubMedPubMedCentral
20.
go back to reference Coll-de-Tuero G, Mata-Cases M, Rodriguez-Poncelas A et al (2012) Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area. BMC Nephrol 13:87PubMedPubMedCentral Coll-de-Tuero G, Mata-Cases M, Rodriguez-Poncelas A et al (2012) Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area. BMC Nephrol 13:87PubMedPubMedCentral
21.
go back to reference Looker HC, Krakoff J, Funahashi T et al (2004) Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 89(8):4010–4017PubMed Looker HC, Krakoff J, Funahashi T et al (2004) Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 89(8):4010–4017PubMed
22.
go back to reference Xu J, Lee ET, Devereux RB et al (2008) A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study. Am J Kidney Dis 51(3):415–424PubMedPubMedCentral Xu J, Lee ET, Devereux RB et al (2008) A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study. Am J Kidney Dis 51(3):415–424PubMedPubMedCentral
23.
go back to reference Sorensen L, Molyneaux L, Yue DK (2002) Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diabetes Res Clin Pract 57(1):45–51PubMed Sorensen L, Molyneaux L, Yue DK (2002) Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diabetes Res Clin Pract 57(1):45–51PubMed
24.
go back to reference Penno G, Solini A, Bonora E et al (2013) Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. J Intern Med 274(2):176–191PubMed Penno G, Solini A, Bonora E et al (2013) Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. J Intern Med 274(2):176–191PubMed
25.
go back to reference Schroeder EB, Bayliss EA, Daugherty SL, Steiner JF (2014) Gender differences in cardiovascular risk factors in incident diabetes. Womens Heal Issues 24(1):e61–e68 Schroeder EB, Bayliss EA, Daugherty SL, Steiner JF (2014) Gender differences in cardiovascular risk factors in incident diabetes. Womens Heal Issues 24(1):e61–e68
26.
go back to reference Minutolo R, Sasso FC, Chiodini P et al (2006) Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings. J Hypertens 24(8):1655–1661PubMed Minutolo R, Sasso FC, Chiodini P et al (2006) Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings. J Hypertens 24(8):1655–1661PubMed
27.
go back to reference Awa WL, Fach E, Krakow D et al (2012) Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120,183 patients from the German/Austrian DPV database. Eur J Endocrinol 167(2):245–254PubMed Awa WL, Fach E, Krakow D et al (2012) Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120,183 patients from the German/Austrian DPV database. Eur J Endocrinol 167(2):245–254PubMed
28.
go back to reference Barrett-Connor E (2013) The Rancho Bernardo Study: 40 years studying why women have less heart disease than men and how diabetes modifies women's usual cardiac protection. Glob Heart 8(2):95–104 Barrett-Connor E (2013) The Rancho Bernardo Study: 40 years studying why women have less heart disease than men and how diabetes modifies women's usual cardiac protection. Glob Heart 8(2):95–104
29.
go back to reference Regensteiner JG, Golden S, Huebschmann AG et al (2015) Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association. Circulation 132(25):2424–2447PubMed Regensteiner JG, Golden S, Huebschmann AG et al (2015) Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association. Circulation 132(25):2424–2447PubMed
30.
go back to reference Kramer HU, Raum E, Ruter G et al (2012) Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study. Cardiovasc Diabetol 11:88PubMedPubMedCentral Kramer HU, Raum E, Ruter G et al (2012) Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study. Cardiovasc Diabetol 11:88PubMedPubMedCentral
31.
go back to reference Gouni-Berthold I, Berthold HK, Mantzoros CS, Bohm M, Krone W (2008) Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 31(7):1389–1391PubMedPubMedCentral Gouni-Berthold I, Berthold HK, Mantzoros CS, Bohm M, Krone W (2008) Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 31(7):1389–1391PubMedPubMedCentral
32.
go back to reference Tran HV, Waring ME, McManus DD et al (2017) Underuse of effective cardiac medications among women, middle-aged adults, and racial/ethnic minorities with coronary artery disease (from the National Health and Nutrition Examination Survey 2005 to 2014). Am J Cardiol 120(8):1223–1229PubMed Tran HV, Waring ME, McManus DD et al (2017) Underuse of effective cardiac medications among women, middle-aged adults, and racial/ethnic minorities with coronary artery disease (from the National Health and Nutrition Examination Survey 2005 to 2014). Am J Cardiol 120(8):1223–1229PubMed
33.
go back to reference Penno G, Solini A, Bonora E et al (2011) Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 29(9):1802–1809PubMed Penno G, Solini A, Bonora E et al (2011) Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 29(9):1802–1809PubMed
Metadata
Title
Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study
Authors
Sunny S. Singh
Jeanine E. Roeters-van Lennep
Roosmarijn F. H. Lemmers
Thijs T. W. van Herpt
Aloysius G. Lieverse
Eric J. G. Sijbrands
Mandy van Hoek
Publication date
01-06-2020
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 6/2020
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-020-01489-6

Other articles of this Issue 6/2020

Acta Diabetologica 6/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.